New insights into major disease pathways made with protein discovery
A new chemical tool has been used to identify hundreds of modified proteins which allows new insights to major diseases.
List view / Grid view
A new chemical tool has been used to identify hundreds of modified proteins which allows new insights to major diseases.
Researchers have used ghost imaging to enhance the imaging speed of nanoscopy, which could make it possible to capture processes in living cells at speeds not previously possible.
Researchers have developed a cell line that allows the mechanisms of prostate cancer bone metastasis to be studied in immunocompetent mice.
A new discovery that leukaemia type B cells can transform into different cells through epigenetic changes could lead to more effective therapies.
A new study has demonstrated for the first time that mutations that affect myosin motor activity result in slower cell movements in vivo.
A technique to 'trick' bacteria into revealing pores in their cell walls has been developed and targeting these could make antibiotics more effective.
A new platform has the potential to better understand what dictates the invasive behaviour of brain tumours.
A world-first compound that can keep cells alive and functioning in a healthy state could be revolutionary for medical emergencies.
Disruption of the MFF-VDAC1 complex could lead to a potential therapeutic target for cancer.
New antibiotics could be designed by discovering the mechanism a weapon bacteria uses to vanquish their competitors.
Researchers have created a new technology which enabled them to discover more about the causes of Huntington’s disease and which can be used to test drugs.
Aparajita Dubey summarises the recent trends in upstream bioprocessing and highlights the challenges and solutions involved in its process development.
Upstream bioprocessing is the epicentre of biologics development, wherein scientists piece together a series of carefully chosen processes with contributing components and parameters to enable the production of highly effective biotherapeutics. Unjulie Bhanot explains why an effective data management system is vital in this quest for the next big therapeutic.
An experiment with mice has successively blocked the immune system's T cells from killing transplanted cells.